netrashetty
Netra Shetty
Applied Biosystems, Inc. (formerly NASDAQ: ABIO) started as GeneCo (Genetic Systems Company), was the name of a pioneer biotechnology company founded in 1981 in Foster City, California, in the San Francisco Bay Area.[1] Through the 1980s and early 1990s it operated independently and manufactured biochemicals and automated genetic engineering and diagnostic research instruments, including the principal brand of DNA sequencing machine used by the Human Genome Project consortium centers. Applied Biosystems' close ties to the consortium project led to the idea for the founding of Celera Genomics (NYSE: CRA) in 1998 as one of several independent competitors to the consortium.[2]
In 1983 Applied Biosystems was delisted from the NASDAQ when it was acquired by the old company known then as Perkin-Elmer (formerly NYSE: PKN). As the PE Applied Biosystems Division under that parent in 1998, it became consolidated with other acquisitions as the primary PE Biosystems Division. In 1999 its parent company reorganized and changed its name to PE Corporation, and the PE Biosystems Group (formerly NYSE: PEB) again became publicly traded, as a tracking stock of its parent, along with its sister tracking stock company, Celera Genomics. In 2000 the parent became Applera Corporation. The Applied Biosystems name also returned that year, in the name change of the tracking stock from PE Biosystems Group to Applera Corporation-Applied Biosystems Group (NYSE: ABI), an S&P 500 company, which remains as a publicly traded operating group within Applera Corp., along with its sibling operating group, Applera Corporation-Celera Group. Applera derives its name from the combination of its two component groups' names, Appl(iedCel)era.[3] In November 2008, a merger between Applied Biosystems and Invitrogen [4] was finalized "creating a global leader in biotechnology reagents and systems". The new company is called Life Technologies
DNA Sequencing by Capillary Electrophoresis
DNA/RNA Detection, Labeling & Synthesis
DNA/RNA Purification
Flow Cytometry
Food Testing & Animal Health
Gene Expression
Genotyping
Human Identification & Forensic DNA
Laser Capture Microdissection
Next-Generation Sequencing
PCR
Pharmaceutical Purification & Analytics
Protein Research
Real-Time PCR
Semiconductor Sequencing
Services
siRNA, miRNA & Non-Coding RNA
WHAT’S NEW:
New Products
Special Offers
ASSAY SEARCHES:
Silencer® siRNA
Custom TaqMan® Array
TaqMan® Gene Expression Assays
TaqMan® MicroRNA Assays
TaqMan® Copy Number Assays
TaqMan® SNP Genotyping Assays
TaqMan® Protein Assays
APPLICATIONS:
Animal Health
Biotherapeutics & Vaccine Production
DNA Sequencing
Epigenetics
Food Pathogen Detection
Gene Expression Analysis
Genotyping & Genetic Variation
Human Identification
Influenza A (H1N1) Research
miRNA & Non-Coding RNA Analysis
Protein Expression
Stem Cell Research
Waterborne Pathogen Detection
Whole Transcriptome Analysis
TECHNOLOGIES:
DNA Sequencing & Fragment Analysis by Capillary Electrophoresis
Flow Cytometry
Laser Capture Microdissection
PCR
Real-Time PCR
Semiconductor Sequencing
The SOLiD™ System: Next
In 1983 Applied Biosystems was delisted from the NASDAQ when it was acquired by the old company known then as Perkin-Elmer (formerly NYSE: PKN). As the PE Applied Biosystems Division under that parent in 1998, it became consolidated with other acquisitions as the primary PE Biosystems Division. In 1999 its parent company reorganized and changed its name to PE Corporation, and the PE Biosystems Group (formerly NYSE: PEB) again became publicly traded, as a tracking stock of its parent, along with its sister tracking stock company, Celera Genomics. In 2000 the parent became Applera Corporation. The Applied Biosystems name also returned that year, in the name change of the tracking stock from PE Biosystems Group to Applera Corporation-Applied Biosystems Group (NYSE: ABI), an S&P 500 company, which remains as a publicly traded operating group within Applera Corp., along with its sibling operating group, Applera Corporation-Celera Group. Applera derives its name from the combination of its two component groups' names, Appl(iedCel)era.[3] In November 2008, a merger between Applied Biosystems and Invitrogen [4] was finalized "creating a global leader in biotechnology reagents and systems". The new company is called Life Technologies
DNA Sequencing by Capillary Electrophoresis
DNA/RNA Detection, Labeling & Synthesis
DNA/RNA Purification
Flow Cytometry
Food Testing & Animal Health
Gene Expression
Genotyping
Human Identification & Forensic DNA
Laser Capture Microdissection
Next-Generation Sequencing
PCR
Pharmaceutical Purification & Analytics
Protein Research
Real-Time PCR
Semiconductor Sequencing
Services
siRNA, miRNA & Non-Coding RNA
WHAT’S NEW:
New Products
Special Offers
ASSAY SEARCHES:
Silencer® siRNA
Custom TaqMan® Array
TaqMan® Gene Expression Assays
TaqMan® MicroRNA Assays
TaqMan® Copy Number Assays
TaqMan® SNP Genotyping Assays
TaqMan® Protein Assays
APPLICATIONS:
Animal Health
Biotherapeutics & Vaccine Production
DNA Sequencing
Epigenetics
Food Pathogen Detection
Gene Expression Analysis
Genotyping & Genetic Variation
Human Identification
Influenza A (H1N1) Research
miRNA & Non-Coding RNA Analysis
Protein Expression
Stem Cell Research
Waterborne Pathogen Detection
Whole Transcriptome Analysis
TECHNOLOGIES:
DNA Sequencing & Fragment Analysis by Capillary Electrophoresis
Flow Cytometry
Laser Capture Microdissection
PCR
Real-Time PCR
Semiconductor Sequencing
The SOLiD™ System: Next